Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 11/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30876165 | 0.84 | NFE2L2 (0.55) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| SCHEMBL5700188 | 0.83 | NFE2L2 (0.58) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29260132 | 0.82 | NFE2L2 (0.54) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| SCHEMBL24458050 | 0.81 | NFE2L2 (0.56) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| SCHEMBL22831254 | 0.81 | NFE2L2 (0.56) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| SCHEMBL27326888 | 0.80 | NFE2L2 (0.55) | NFE2L2PLAUPDGFRBPDGFRAALDH1A1 | |
| SCHEMBL3721266 | 0.79 | NFE2L2 (0.54) | NFE2L2PLAUPOLBMEN1NPC1 | |
| SCHEMBL1256203 | 0.75 | NPC1 (0.49) | NFE2L2PLAUALDH1A1POLBSLC40A1 | |
| SCHEMBL29516525 | 0.75 | NFE2L2 (0.40) | NFE2L2ALDH1A1MEN1KMT2A | |
| SCHEMBL4998230 | 0.75 | KDM4E (0.45) | PLAUALDH1A1NPC1GAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116200393-A | Mixed broad-spectrum nucleic acid aptamer for simultaneously detecting 9 sulfonamide drugs | 福州大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-100358901-C | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE INC (US) | 2008-01-02 | — | — | CN | disclosed |
| CN-1329397-C | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE PHARMACY (US) | 2007-08-01 | — | — | CN | disclosed |
| CN-1781916-A | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE INC (US) | 2006-06-07 | — | — | CN | disclosed |
| CN-1568325-A | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE (US) | 2005-01-19 | — | — | CN | disclosed |